What is the current valuation of the transdermal drug-delivery-systems market in Japan?

The market valuation was $1324.28 Million in 2024. Read More

What is the projected market size for the transdermal drug-delivery-systems market in Japan by 2035?

The projected valuation for 2035 is $2500.0 Million. Read More

What is the expected CAGR for the Japan transdermal drug-delivery-systems market during the forecast period 2025 - 2035?

The expected CAGR is 5.95% during the forecast period 2025 - 2035. Read More

Which technology segment had the highest valuation in the Japan transdermal drug-delivery-systems market?

The Transdermal Patches segment had a valuation range of $600.0 Million to $1200.0 Million. Read More

What are the key applications driving the transdermal drug-delivery-systems market in Japan?

Key applications include Pain Management, Hormone Replacement Therapy, and Cardiovascular Diseases. Read More

Which end-use segment is expected to show significant growth in the Japan transdermal drug-delivery-systems market?

The Hospitals and Pharmaceutical Companies segments are expected to show significant growth, each ranging from $400.0 Million to $800.0 Million. Read More

Who are the leading players in the Japan transdermal drug-delivery-systems market?

Key players include Johnson & Johnson, Mylan N.V., Novartis AG, and Boehringer Ingelheim. Read More

What formulation types are prevalent in the Japan transdermal drug-delivery-systems market?

Prevalent formulation types include Drug-in-Patch, Reservoir Type, and Matrix Type. Read More

How does the market for microneedle patches compare to other technologies in Japan?

The Microneedle Patches segment ranges from $150.0 Million to $300.0 Million, indicating a smaller market compared to Transdermal Patches. Read More

What is the significance of the projected growth in the Japan transdermal drug-delivery-systems market?

The projected growth suggests a robust demand for innovative drug delivery methods, potentially enhancing patient compliance and therapeutic outcomes. Read More

Japan Transdermal Drug Delivery Systems Market

ID: MRFR/MED/52260-HCR

200 Pages

Vikita Thakur

Last Updated: February 06, 2026

Japan Transdermal Drug Delivery Systems Market Research Report: Size, Share, Trend Analysis By Product (Transdermal Patches, Semisolids) and By Technology (Electric Current, Iontophoresis, Electroporation, Ultrasound, Microporation) - Growth Outlook & Industry Forecast 2025 To 2035

Japan Transdermal Drug Delivery Systems Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Technology (USD Million)
  1. 4.1.1 Microneedle Patches
  2. 4.1.2 Transdermal Patches
  3. 4.1.3 Iontophoresis
  4. 4.1.4 Sonophoresis
  5. 4.1.5 Thermal Patches
2. 4.2 Medical Device, BY Application (USD Million)
  1. 4.2.1 Pain Management
  2. 4.2.2 Hormone Replacement Therapy
  3. 4.2.3 Cardiovascular Diseases
  4. 4.2.4 Neurological Disorders
  5. 4.2.5 Smoking Cessation
3. 4.3 Medical Device, BY End-use (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Home Healthcare
  3. 4.3.3 Pharmaceutical Companies
  4. 4.3.4 Research Institutes
4. 4.4 Medical Device, BY Formulation Type (USD Million)
  1. 4.4.1 Drug-in-Patch
  2. 4.4.2 Reservoir Type
  3. 4.4.3 Matrix Type
  4. 4.4.4 Microreservoir Type
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Johnson & Johnson (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Mylan N.V. (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Novartis AG (CH)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Boehringer Ingelheim (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Teva Pharmaceutical Industries Ltd. (IL)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Hikma Pharmaceuticals PLC (GB)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Purdue Pharma L.P. (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 AstraZeneca PLC (GB)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Fresenius Kabi AG (DE)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 JAPAN MARKET ANALYSIS BY TECHNOLOGY
3. 6.3 JAPAN MARKET ANALYSIS BY APPLICATION
4. 6.4 JAPAN MARKET ANALYSIS BY END-USE
5. 6.5 JAPAN MARKET ANALYSIS BY FORMULATION TYPE
6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
12. 6.12 MEDICAL DEVICE, BY TECHNOLOGY, 2024 (% SHARE)
13. 6.13 MEDICAL DEVICE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
14. 6.14 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE)
15. 6.15 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million)
16. 6.16 MEDICAL DEVICE, BY END-USE, 2024 (% SHARE)
17. 6.17 MEDICAL DEVICE, BY END-USE, 2024 TO 2035 (USD Million)
18. 6.18 MEDICAL DEVICE, BY FORMULATION TYPE, 2024 (% SHARE)
19. 6.19 MEDICAL DEVICE, BY FORMULATION TYPE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TECHNOLOGY, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY END-USE, 2025-2035 (USD Million)
  4. 7.2.4 BY FORMULATION TYPE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

Japan Medical Device Market Segmentation

Medical Device By Technology (USD Million, 2025-2035)

Microneedle Patches
Transdermal Patches
Iontophoresis
Sonophoresis
Thermal Patches

Medical Device By Application (USD Million, 2025-2035)

Pain Management
Hormone Replacement Therapy
Cardiovascular Diseases
Neurological Disorders
Smoking Cessation

Medical Device By End-use (USD Million, 2025-2035)

Hospitals
Home Healthcare
Pharmaceutical Companies
Research Institutes

Medical Device By Formulation Type (USD Million, 2025-2035)

Drug-in-Patch
Reservoir Type
Matrix Type
Microreservoir Type

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”